Tuesday, 4 October, 2022
HomeWorldBhutan to not allow sale of Patanjali's Coronil, says drug not approved...

Bhutan to not allow sale of Patanjali’s Coronil, says drug not approved by its regulatory body

Bhutan's Drug Regulatory Authority has said there is no cure for Covid-19 yet and it won't allow the sale of any medicine which claims to do so.

Text Size:

New Delhi: The drug regulatory body of Bhutan has said that Patanjali’s Coronil, which the company’s founder Ramdev has touted as a cure for Covid-19, will not be sold in the country.

The Drug Regulatory Authority (DRA) of Bhutan, which oversees import and sale of medicines in the country, had last week said that Coronil has not been approved by it.

The body, which is also responsible for the safety, quality and efficacy of medicines sold in Bhutan, asserted there were “no approved medicines yet in the world to treat Covid-19” and it won’t allow pharmacies to sell products that claim to treat the novel coronavirus.

Kunzang Dorji, DRA’s head of inspection division, has been quoted as saying that the Patanjali outlet in Thimpu was inspected but it didn’t have Coronil.

Bhutan has so far recorded 77 cases of Covid-19, with 44 recoveries and zero deaths.

Also read: Modi govt steps up pressure on Patanjali, seeks more information on Coronil study

Patanjali Ayurveda’s U-turn

Launched last week, Coronil has since run into an array of controversies for claiming to cure coronavirus.

Most recently, a 17-member taskforce, formed to investigate the efficacy of Coronil, had submitted a report to the Ministry of AYUSH stating the drug shouldn’t be used as cure for coronavirus.

Taking a complete U-turn on claims it had made just a week ago, Patanjali Ayurveda CEO Acharya Balkrishna Tuesday said the firm never positioned Coronil as a cure or means to control coronavirus.

“We never told the medicine (Coronil) can cure or control coronavirus. We said that we had made medicines and used them in clinical controlled trials which cured corona patients. There is no confusion in it,” he told news agency ANI.

Balkrishna’s statement came days after Ramdev, in a press conference last week, said “two Ayurveda-based medicines had shown 100 per cent favourable results during clinical trials on Covid-19 infected patients”.

Also read: Patanjali intent behind ‘Covid cure’ not wrong but should’ve followed protocol: Ayush minister


Subscribe to our channels on YouTube & Telegram

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism


  1. Few questions

    1. How did ICMR allow HCQ for treatement was a study done and report published. Trial on patient without report published.
    2. Remdesvir same question as above.
    3 Coronil and aryurvedic medicine with a combination of herbs which is used for ages

    Please donot bring a allopathy template for ayurvedic medicine .
    The problem with many is it is developed by India and by a man wearing saffron. So this hatred

  2. “We said that we had made medicines and used them in clinical controlled trials which cured corona patients.” – – – No, you selected some herbs with minimum thought, deceptively named it Coronil and put them in a trial knowing that all the young patients with no pre-existing conditions will get better anyway, even without treatment, and called it a resounding success of your basically placebo kit.

    Bhutan had 77 cases and 0 deaths. More cases than your trial, more cured (normal remissions) patients, and no “cures” used. So no medicine is just as good as Coronil.

    No one sensible would call what Patanjali did, a trial. Little wonder that they did not even go for a publication and instead hurriedly started with TV campaign first.

    Patanjali guys can sell you a bridge.

    • Groundbreaking journalism. Im sure the reporter here must have spent money, worked really hard, taken inspiration from senior journalists just so that she could write a story on what Bhutan’s Drug Authority had said a week back. Also, kudos to the reporter for using ‘Drug regulatory body/Authority of Bhutan’ twice in 5-6 lines. The need to stretch empty words into an article must be quite high. Yet again, a 3 tweet thread has been converted into an article.

Comments are closed.

Most Popular